{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:20:19Z","timestamp":1785320419081,"version":"3.55.0"},"reference-count":41,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.2967\/jnumed.114.138032","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T07:59:33Z","timestamp":1403251173000},"page":"1281-1287","source":"Crossref","is-referenced-by-count":21,"title":["Safety Analysis of 10 Clinical Trials and for 13 Years After First Approval of Ioflupane <sup>123<\/sup>I Injection (DaTscan)"],"prefix":"10.2967","volume":"55","author":[{"given":"Donald G.","family":"Grosset","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Tatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nin","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Seibyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor D.","family":"Grachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"2021051712063326000_55.8.1281.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(01)00211-6"},{"key":"2021051712063326000_55.8.1281.2","unstructured":"DaTscan\u2122 [US package insert]. Arlington Heights, IL: GE Healthcare, Medi-Physics Inc.; 2011."},{"key":"2021051712063326000_55.8.1281.3","unstructured":"European Medicines Agency. DaTSCAN\u2122 Summary of Product Characteristics. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000266\/human_med_000739.jsp&mid=WC0b01ac058001d124. Accessed May 21, 2014."},{"key":"2021051712063326000_55.8.1281.4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.110122"},{"key":"2021051712063326000_55.8.1281.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304436"},{"key":"2021051712063326000_55.8.1281.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301695"},{"key":"2021051712063326000_55.8.1281.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000380"},{"key":"2021051712063326000_55.8.1281.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2011.00583.x"},{"key":"2021051712063326000_55.8.1281.9","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10482"},{"key":"2021051712063326000_55.8.1281.10","unstructured":"U.S. FDA. PCNS Advisory Committee Briefing Document. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/UCM176192. Accessed May 21, 2014."},{"key":"2021051712063326000_55.8.1281.11","unstructured":"MedDRA 11.0 Review. Meddrahelp.com. http:\/\/www.meddrahelp.com\/PDF\/MedDRA_11_0_Review.pdf. Accessed June 10, 2014."},{"key":"2021051712063326000_55.8.1281.12","unstructured":"MedDRA 13.1 Review. Meddrahelp.com. http:\/\/www.meddrahelp.com\/PDF\/MedDRA_13_1.pdf. Accessed June 10, 2014."},{"key":"2021051712063326000_55.8.1281.13","unstructured":"MedDRA 15.0 Review. Meddrahelp.com. http:\/\/www.meddrahelp.com\/pdf\/MedDRA_15_0.pdf. Accessed June 10, 2014."},{"key":"2021051712063326000_55.8.1281.14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajgp.10.1.36"},{"key":"2021051712063326000_55.8.1281.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2276-8"},{"key":"2021051712063326000_55.8.1281.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2207-8"},{"key":"2021051712063326000_55.8.1281.17","first-page":"57","article-title":"123-I Ioflupane SPECT measures of Parkinson disease progression in the Parkinson Progression Marker Initiative (PPMI) trial","volume":"54","author":"Seibyl","year":"2013","journal-title":"J Nucl Med."},{"key":"2021051712063326000_55.8.1281.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70117-0"},{"key":"2021051712063326000_55.8.1281.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-005-1922-9"},{"key":"2021051712063326000_55.8.1281.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2013.04.076"},{"key":"2021051712063326000_55.8.1281.21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.3.294"},{"key":"2021051712063326000_55.8.1281.22","first-page":"1500","article-title":"Iodine-123-\u03b2CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients","volume":"39","author":"Seibyl","year":"1998","journal-title":"J Nucl Med."},{"key":"2021051712063326000_55.8.1281.23","unstructured":"Mirapex\u00ae (pramipexole) [US package insert]. Ridgefield, CT: Boehringer Ingelheim; 2013."},{"key":"2021051712063326000_55.8.1281.24","unstructured":"Requip (ropinirole) XL [US package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2009."},{"key":"2021051712063326000_55.8.1281.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-007-0621-0"},{"key":"2021051712063326000_55.8.1281.26","first-page":"359","article-title":"Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects","volume":"48","author":"Booij","year":"2007","journal-title":"J Nucl Med."},{"key":"2021051712063326000_55.8.1281.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.078337"},{"key":"2021051712063326000_55.8.1281.28","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.157370"},{"key":"2021051712063326000_55.8.1281.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.100784"},{"key":"2021051712063326000_55.8.1281.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1726-4"},{"key":"2021051712063326000_55.8.1281.31","unstructured":"Howlader N Noone AM Krapcho M ., eds. SEER Cancer Statistics Review, 1975\u20132010, National Cancer Institute. http:\/\/seer.cancer.gov\/csr\/1975_2010\/. 2013. Accessed May 21, 2014."},{"key":"2021051712063326000_55.8.1281.32","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1077(199611)11:6<483::AID-HUP818>3.0.CO;2-9"},{"key":"2021051712063326000_55.8.1281.33","first-page":"745","article-title":"Metabolism of 123I-FP-CIT in humans","volume":"36","author":"Tanaka","year":"1999","journal-title":"Kaku Igaku."},{"key":"2021051712063326000_55.8.1281.34","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050190"},{"key":"2021051712063326000_55.8.1281.35","unstructured":"American Nuclear Society. Radiation Dose Chart. http:\/\/www.ans.org\/pi\/resources\/dosechart\/. Accessed June 10, 2014."},{"key":"2021051712063326000_55.8.1281.36","unstructured":"American College of Radiology and Radiological Society of North America. Patient Safety: Radiation Dose in X-Ray and CT Exams. RadiologyInfo.org. http:\/\/www.radiologyinfo.org\/en\/safety\/index.cfm?pg=sfty_xray. Accessed May 21, 2014."},{"key":"2021051712063326000_55.8.1281.37","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.110106"},{"key":"2021051712063326000_55.8.1281.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2012.03784.x"},{"key":"2021051712063326000_55.8.1281.39","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1111\/j.1468-1331.2012.03859.x","article-title":"EFNS task force: the use of neuroimaging in the diagnosis of dementia","volume":"19","author":"Filippi","year":"2012","journal-title":"Eur J Neurol."},{"key":"2021051712063326000_55.8.1281.40","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12022"},{"key":"2021051712063326000_55.8.1281.41","unstructured":"National Institute for Health and Clinical Excellence (NICE). NICE Clinical Guideline 35: Parkinson's disease: diagnosis and management in primary and secondary care. Nice.org. http:\/\/www.nice.org.uk\/nicemedia\/live\/10984\/30088\/30088.pdf. June 2006. Accessed May 21, 2014."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.114.138032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T19:55:33Z","timestamp":1621281333000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.114.138032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,19]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.2967\/jnumed.114.138032"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.114.138032","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,19]]}}}